Erdogan-Trinkaus Ipek - Insider Non-Derivative Transactions at Eton Pharmaceuticals, Inc. (ETON) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 12, 2025, Erdogan-Trinkaus Ipek's relationship to Eton Pharmaceuticals, Inc. (ETON) is Officer (Chief Commercial Officer), and currently has 2,403 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ETON insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Erdogan-Trinkaus Ipek - Insider Non-Derivative Transactions of ETON Common Stock

Erdogan-Trinkaus Ipek - Insider Non-Derivative Transactions at ETON

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	85	16.9	2403